Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
26.07
+0.62 (2.44%)
At close: Nov 20, 2025, 4:00 PM EST
25.92
-0.15 (-0.58%)
After-hours: Nov 20, 2025, 6:02 PM EST
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $1.59 billion as of November 20, 2025. Its market cap has decreased by -35.29% in one year.
Market Cap
1.59B
Enterprise Value
1.47B
1-Year Change
-35.29%
Ranking
Category
Stock Price
$26.07
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $1.59B, an increase of 327.91%. That is a compound annual growth rate of 22.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 1.56B | -43.58% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | 6.82B | 881.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.72B |
| Johnson & Johnson | 489.33B |
| AbbVie | 403.99B |
| UnitedHealth Group | 282.45B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 234.10B |
| Abbott Laboratories | 216.30B |